Letters and drug alerts sent to healthcare professionals in April 2019

Letters were sent about alemtuzumab (Lemtrada), Selenase (sodium selenite pentahydrate), and Erelzi▼ (etanercept).


In April 2019, the following letters were sent to healthcare professionals:

Drug alerts

For the latest alerts, including those from May 2019 on Macopharma intravenous infusion bags and Co-amoxiclav Power for Oral Suspension, see Alerts and recalls for drugs and medical devices.

Article citation: Drug Safety Update volume 12, issue 10: May 2019: 5.

Published 17 May 2019